Characterization and Risk Factors of Folliculitis After Hair Transplantation

March 20, 2023 updated by: Nanfang Hospital of Southern Medical University
We retrospectively reviewed 1317 patients who had undergone HT and completed 9-month follow-up between January 2018 and June 2021 at 4 medical centers. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Postoperative folliculitis is a common complication after hair transplantation (HT) and requires effective preventive interventions. This study aimed to characterize postoperative folliculitis and determine the risk factors in patients underwent HT. The study was conducted at 4 clinical sites: Nanfang Hospital of Southern Medical University, the First Affiliated Hospital, Zhejiang University School of Medicine, the Affiliated Hospital of Guilin Medical University, and Peking University Third Hospital. Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.

Study Type

Observational

Enrollment (Actual)

1317

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Guangdong
      • Guangzhou, Guangdong, China, 510080
        • Nanfang Hospital of Southern Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected.

Description

Inclusion Criteria:

- 1. Healthy adults between the ages of 18 ~ 60

2. patients suitable for autologous hair transplantation according to "the standard of hair transplantation"

Exclusion Criteria:

  1. Coagulation disorders, pregnancy and lactation, immunosuppression
  2. With severe mental and psychological illness, impairment of body image
  3. All kinds of immune-related alopecia in the progressive active stage
  4. Patients judged by the investigator to be unsuitable for this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with postoperative folliculitis
Patients presented folliculitis in surgical-area lesions after hair transplantation within 9-month follow up.
Other: no intervention
no intervention
patients without postoperative folliculitis
Patients didn't present folliculitis in surgical-area lesions after hair transplantation within 9-month follow up.
Other: no intervention
no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
folliculitis
Time Frame: 9 months after hair transplantation
patients present folliculitis after hair transplantation
9 months after hair transplantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nanfang Hospital of Southern Medical University

Investigators

  • Study Chair: Zhiqi Hu, PhD, Nanfang Hospital of Southern Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

June 1, 2021

Study Completion (Actual)

October 1, 2022

Study Registration Dates

First Submitted

March 20, 2023

First Submitted That Met QC Criteria

March 20, 2023

First Posted (Actual)

March 31, 2023

Study Record Updates

Last Update Posted (Actual)

March 31, 2023

Last Update Submitted That Met QC Criteria

March 20, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NFEC-2020-152

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe